UN Photo/Christopher Black Events | 04 February 2020 MSF statements at WHO Executive Board 146th session 1 min UN Photo/Christopher Black UN Photo/Christopher Black MSF representatives are attending the 146th session of the WHO executive board meetings and will be speaking on a number of topics. Statement | 03 February 2020 Research and development WHO 146th EB - 2.1 - WHO reform Involvement of non-State actors in WHO’s governing bodies 2 min Statement | 04 February 2020 Tropical & neglected diseases WHO 146th EB -13 (EB146/14) – Neglected tropical diseases 2 min Statement | 04 February 2020 Research and development WHO 146th EB - 10 (EB146/11) – Ending tuberculosis 2 min Statement | 04 February 2020 Research and development WHO 146th EB -14 (EB146/15) – Global strategy and plan of action on public health, innovation and intellectual property 2 min Don't miss out! Sign up to stay updated and find out how you can get involved. Email Address Data protection consent I want to receive emails from MSF and I have read and agree with the privacy policy. Read, watch, share Filter by - Any -EventsIssue briefLetterPress releaseSpeechStatement Statement | 04 February 2020 Tropical & neglected diseases WHO 146th EB -13 (EB146/14) – Neglected tropical diseases 2 min UN Photo/Christopher Black Events Events | 22 January 2024 MSF statements at WHO Executive Board 154th session 1 min Photograph by Maya Abu Ata Statement Statement | 22 January 2024 Diabetes MSF statement on EB154/7 - Follow up to the political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases (NCDs) 1 min Photo credit: MSF/Alexandre Marcou Statement Statement | 22 January 2024 Vaccines MSF statement on EB 154/9 - Immunization Agenda 2030 2 min Photo credit: Siddharth Singh Statement Statement | 22 January 2024 Tuberculosis MSF statement on EB154/10 - End TB Strategy 2 min Photograph by Ghada Safaan Statement Statement | 22 January 2024 Tropical & neglected diseases MSF statement on EB 154/11 - Road map for neglected tropical diseases 2021-2030 1 min Photo credit: MSF/SORIYA Statement Statement | 22 January 2024 Antimicrobial resistance MSF statement on EB 154/13 - Antimicrobial resistance (AMR): accelerating national and global responses 1 min Statement | 01 February 2023 Research and development MSF Statement on EB152/7 - Substandard and falsified medical products 1 min Load More
Statement | 03 February 2020 Research and development WHO 146th EB - 2.1 - WHO reform Involvement of non-State actors in WHO’s governing bodies 2 min
Statement | 04 February 2020 Tropical & neglected diseases WHO 146th EB -13 (EB146/14) – Neglected tropical diseases 2 min
Statement | 04 February 2020 Research and development WHO 146th EB - 10 (EB146/11) – Ending tuberculosis 2 min
Statement | 04 February 2020 Research and development WHO 146th EB -14 (EB146/15) – Global strategy and plan of action on public health, innovation and intellectual property 2 min
Statement | 04 February 2020 Tropical & neglected diseases WHO 146th EB -13 (EB146/14) – Neglected tropical diseases 2 min
UN Photo/Christopher Black Events Events | 22 January 2024 MSF statements at WHO Executive Board 154th session 1 min
Photograph by Maya Abu Ata Statement Statement | 22 January 2024 Diabetes MSF statement on EB154/7 - Follow up to the political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases (NCDs) 1 min
Photo credit: MSF/Alexandre Marcou Statement Statement | 22 January 2024 Vaccines MSF statement on EB 154/9 - Immunization Agenda 2030 2 min
Photo credit: Siddharth Singh Statement Statement | 22 January 2024 Tuberculosis MSF statement on EB154/10 - End TB Strategy 2 min
Photograph by Ghada Safaan Statement Statement | 22 January 2024 Tropical & neglected diseases MSF statement on EB 154/11 - Road map for neglected tropical diseases 2021-2030 1 min
Photo credit: MSF/SORIYA Statement Statement | 22 January 2024 Antimicrobial resistance MSF statement on EB 154/13 - Antimicrobial resistance (AMR): accelerating national and global responses 1 min
Statement | 01 February 2023 Research and development MSF Statement on EB152/7 - Substandard and falsified medical products 1 min
